Introduction: Preservation of residual hearing in cochlear implant recipients has been demonstrated to be possible and provides the potential benefit of combined electric and acoustic auditory stimulation. A prototype 16-mm multichannel array has been designed to facilitate placement of 22 electrodes without damage to intracochlear structures. The electrode array is suitable for insertion via the round window membrane (RWM) or a small cochleostomy. Aim: To evaluate the insertion trajectory and the presence of trauma to intracochlear structures with the prototype electrode inserted by either the RWM or a scala tympani cochleostomy. Materials and Methods: Eighteen fresh frozen human temporal bones were prepared for cochlear implantation using a standard transmastoid facial recess technique. Twelve electrodes were implanted at the University of Melbourne and 6 at the Medizinische Hochschule Hannover. In Melbourne fluoroscopy was used to monitor the insertions. Twelve prototype electrodes were inserted via the RWM. A further 6 electrodes were inserted via a small scala tympani cochleostomy. The cochleostomy was sited inferior to the RWM to avoid trauma to the basilar membrane and spiral ligament. Specimens were embedded and fixed with acrylic resin and the cochleae then examined histologically at 200-µm intervals using a grinding and polishing technique. Results: Full insertion of the electrode was achieved without significant resistance in all RWM and cochleostomy specimens. In two RWM specimens fold-over of the electrode tip occurred, and in one specimen the electrode penetrated the spiral ligament to lie in an ‘endosteal ‘position. In one cochleostomy specimen the electrode was rotated within the cochlea to face laterally rather than towards the modiolus. The final electrode position differed for the two groups, with the electrodes inserted via the RWM lying in a more perimodiolar position along the first part of the basal turn. The average depth of insertion was 240° for the RWM electrodes and 255° for the cochleostomy electrodes. Histologic examination showed no damage in any specimen to the modiolus, osseous spiral lamina or basilar membrane. Conclusions: A prototype hearing preservation electrode array was inserted by either a RWM or a scala tympani cochleostomy without evidence of significant intracochlear trauma.

1.
Adunka O, Gsttoetner W, Hambeck M, Unkelbach MH, Radeloff A, Kiefer J; Preservation of basal cochlear structures in cochlear implantation. ORL J Otorhinolaryngol Relat Spec 2004;66:306–312.
2.
Baskent D, Shannon RV: Interactions between electrode insertion depth and frequency-place mapping. J Acoust Soc Am 2005;117:1405–1416.
3.
Blamey P, Dooley, Parisi, Clark G: Pitch comparisons of acoustically and electrically evoked auditory sensations. Hear Res 1996;99:139–150.
4.
Briggs R, Tykocinski M, Saunders E, Dahm MC, Hellier W, Pyman B: Surgical implications of perimodiolar electrode designs: avoiding intracochlear damage and scala vestibuli insertions. Cochlear Implant Int 2001;2:135–149.
5.
Briggs RJS, Tykocinski M, Stidham K, Roberson JB: Cochleostomy site: implications for electrode placement and hearing preservation. Acta Otolaryngol 2005;125:870–876.
6.
Dahm MC, Xu J, Tykocinski M, Shepherd RK, Clark GM: Post mortem study of the intracochlear position of the Nucleus Standard 33 electrode array. Proc 5th Eur Symp Paediatr Cochlear Implantat, Antwerp, June 2000.
7.
Gantz BJ, Turner C, Gfeller KE, Lowder MW: Preservation of hearing in cochlear implant surgery: advantages of combined electrical and acoustical speech processing. Laryngoscope 2005;115:796–802.
8.
Gstoettner W, Kiefer J, Baumgartner WD, Pok S, Peters S, Adunka O: Hearing preservation in cochlear implantation for electric acoustic stimulation. Acta Otolaryngol 2004;124:348–352.
9.
Gstoettner W, Plenk H Jr, Franz P, Hamzavi J, Baumgartner W, Czerny C, Ehrenberger K: Cochlear implant deep electrode insertion: extent of insertional trauma. Acta Otolaryngol 1997;117:274–277.
10.
Gstoettner W, Pok SM, Peters S, Kiefer J, Adunka O: Cochlear implantation with preservation of residual deep frequency hearing. HNO 2005;53:784–790.
11.
James C, Albegger K , Battmer R, Burdo S, Deggouj N, Deguine O, Dillier N, Gersdorff M, Laszig R, Lenarz T, Rodriguez MM, Mondain M, Offeciers E, Macias AR, Ramsden R, Sterkers O, Von Wallenberg E, Weber B, Fraysse B: Preservation of residual hearing with cochlear implantation: how and why. Acta Otolaryngol 2005;125:481–491.
12.
James C, Blamey P, Shallop J, Incerti P, Nicholas AM: Contralateral masking in cochlear implant users with residual hearing in the non-implanted ear. Audiol Neurootol 2001;6:87–97.
13.
Kennedy DW: Multichannel intracochlear electrodes: mechanism of insertion trauma. Laryngoscope 1987;97:42–49.
14.
Kiefer J, Gstoettner W, Baumgatner W, Pok SM, Tillein J, Ye Q, von Ilberg C: Conservation of low frequency hearing in cochlear implantation. Acta Otolaryngol 2004;124:272–280.
15.
Neumann M, Aschendorff A, Schipper J, Laszig R, Klenzner T: The influence of insertion depth on the preservation of residual hearing after cochlear implantation. Laryngorhinotologie 2005;84:113–116.
16.
Skarzynski H, Lorens, A, D’Haese P, Walkowiak A, Piotrowska A, Sliwa L, Anderson I: Preservation of residual hearing in children and post-lingually deafened adults after cochlear implantation: an initial study. ORL 2002;64:247–253.
17.
Tykocinski M, Saunders E, Cohen L, Treaba C, Briggs RJS, Gibson P: The Contour electrode array, safety study and initial patient trials using a new peri-modiolar electrode design. Otol Neurotol 2001;21:205–211.
18.
Von Ilberg C, Kiefer J, Tillein J, Pfenningdorff T, Hartmann R, Sturzebecher E, Klinke R: Electric-acoustic stimulation of the auditory system. New technology for severe hearing loss. ORL J Otorhinolaryngol Relat Spec 1999;61:334–340.
19.
Webb RL, Clark GM, Shepherd RK, Franz BK, Pyman BC: The biologic safety of the Cochlear Corporation multiple electrode intracochlear implant. Am J Otol 1988;9:8–13.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.